Perspective on biotech leaders

Blue Latitude Health|27th November 2017

The future of healthcare starts here...

As 2017 draws to a close we speak to seven biotech leaders, ranging from CEO's to medical information leaders and marketing directors, as well as genomics experts, clinical diagnostic professionals and academics.

In each interview these trailblazers reveal exclusive deep insights into the future of the industry, exploring how changes in pricing, regulation and technological and scientific innovation are transforming the way we view healthcare.

Download the magazine to find out about:

  • Commercialising cutting-edge stem cell therapies
  • The patient-centric heart of the industry
  • The changing role of medical information in precision medicine
  • What commercial innovation really means for biotech companies
  • How to overcome the skills crisis plaguing the sector
  • The future of clinical diagnostics and liquid biopsy
  • Big data, privacy and the rise of genomic testing.
 

Precision paediatrics: Treating patients with CAR-T

Guest Blogger|9th July 2019

Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking CAR-T therapy for the first patient in Europe, and how the centre of excellence has adapted to make precision medicine a reality

read more

What does it mean to be an agile organisation

Guest Blogger|27th June 2019

We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

read more

Battling breast cancer with precision medicine (Part 2)

Natasha Cowan|20th June 2019

Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives his side of the story and explains how industry can help oncologists treat more patients with targeted therapies.

read more